GlaxoSmithKline Paxil Label Has Inadequate Withdrawal Warnings, Suit Says
Executive Summary
GlaxoSmithKline Paxil labeling failed to provide adequate warning about the incidence of dependency and withdrawal symptoms, a class action lawsuit alleges.